AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial.

AstraZeneca said its experimental weight loss pill was well tolerated by patients ... profile of experimental weight loss drugs. Roche Holding shares slumped 4.5% in early European trading in ...

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...

Going beyond the pill is proving to be a win/win for patients ... which was supported by Roche Diabetes Care, and delivered by accredited therapists who had been trained to understand and manage ...

The Swiss pharma company Roche is developing an oral GLP-1 weight ... to develop weight loss treatments as a once-daily oral pill. It is believed that this method could expand the market for ...

In an interview with pharmaphorum, Marius Scholtz, country medical lead for Roche UK, said the drug will have around the same yearly cost in relapsing disease as Novartis’ once-daily pill ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Viking Therapeutics reported promising early results for its experimental obesity pill, with increased weight loss at higher ...

Patients with rare diseases in India, like Saifullah Khalidi with spinal muscular atrophy (SMA), struggle to afford ...

In the effort to expand approaches to treating Alzheimer’s beyond targeting amyloid, some companies have sought to target ...